tPA is considered a gold standard for treatment of patients with ischemic strokes.
Mechanism: Works by dissolving clots and restoring/improving blood perfusion to part of the brain that was previously impeded.
Important: Differentiate ischemic and hemorrhagic stroke by administering CT scan. tPA will not be useful in hemorrhagic strokes as decreased perfusion to brain is result of intracranial bleeding as opposed to a vascular obstruction.
When to give: Must be given within 3-4.5 hours from onset of stroke symptoms. *NOTE: it is from the time the patient was last asymptomatic, hence if a patient awakes with stroke symptoms, they were last asymptomatic whatever time they fell asleep.
How is it administered: IV
1. Davis SM, Donnan GA (June 2009). “4.5 hours: the new time window for tissue plasminogen activator in stroke”. Stroke 40 (6): 2266–7.
2. Fonarow GC, Zhao X, Smith EE, et al. Door-to-Needle Times for Tissue Plasminogen Activator Administration and Clinical Outcomes in Acute Ischemic Stroke Before and After a Quality Improvement Initiative. JAMA. 2014;311(16):1632-1640. doi:10.1001/jama.2014.3203.
A common finding described on computed tomography (CT) imaging. A disease with a peribronchovascular distribution…
It is not clearly understood why patients with pulmonary hypertension (PH) develop pericardial effusions. However,…
The two drugs are not interchangeable nor dose equivalents. Mycophenolate mofetil (Cellcept) is a semi…